https://sputniknews.com/india/202104211082686916-india-reduces-duty-on-importing-life-saving-remdesivir-from-bangladesh-amid-domestic-shortage/
Facing a virulent second COVID wave, India is already ramping up its manufacturing capacity to produce the drug Remdesivir, which is being extensively employed by doctors to manage COVID symptoms in severely ill patients. On Monday, India reduced the import duty on the drug, paving the way for its import from neighbouring Bangladesh.
The Indian government on Wednesday reduced the import duty on Remdesivir, a key drug being employed by doctors to manage COVID symptoms, amid a widespread shortage of the medicine as the nation grapples with a virulent second wave.
“Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has reduced the customs duty on Remdesivir and its API/KSM. This step will further augment domestic availability of Remdesivir injections, India’s federa